These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin. Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P. Mol Pharmacol; 1984 May; 25(3):425-30. PubMed ID: 6427599 [Abstract] [Full Text] [Related]
4. Oxidized aldose reductase: in vivo factor not in vitro artifact. Grimshaw CE, Lai CJ. Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700 [Abstract] [Full Text] [Related]
9. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Roitel O, Scrutton NS, Munro AW. Biochemistry; 2003 Sep 16; 42(36):10809-21. PubMed ID: 12962506 [Abstract] [Full Text] [Related]
10. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase. Tiedge M, Richter T, Lenzen S. Arch Biochem Biophys; 2000 Mar 15; 375(2):251-60. PubMed ID: 10700381 [Abstract] [Full Text] [Related]
12. Glutathione dependent modification of bovine lens aldose reductase. Cappiello M, Voltarelli M, Giannessi M, Cecconi I, Camici G, Manao G, Del Corso A, Mura U. Exp Eye Res; 1994 Apr 15; 58(4):491-501. PubMed ID: 7925685 [Abstract] [Full Text] [Related]
13. The kinetic mechanism of human placental aldose reductase and aldehyde reductase II. Bhatnagar A, Das B, Gavva SR, Cook PF, Srivastava SK. Arch Biochem Biophys; 1988 Mar 15; 261(2):264-74. PubMed ID: 3128169 [Abstract] [Full Text] [Related]
14. Thiol modification and site directed mutagenesis of the flavin domain of spinach NADH:nitrate reductase. Trimboli AJ, Quinn GB, Smith ET, Barber MJ. Arch Biochem Biophys; 1996 Jul 01; 331(1):117-26. PubMed ID: 8660690 [Abstract] [Full Text] [Related]
15. Involvement of cysteine residues in catalysis and inhibition of human aldose reductase. Site-directed mutagenesis of Cys-80, -298, and -303. Petrash JM, Harter TM, Devine CS, Olins PO, Bhatnagar A, Liu S, Srivastava SK. J Biol Chem; 1992 Dec 05; 267(34):24833-40. PubMed ID: 1332968 [Abstract] [Full Text] [Related]
17. Studies of the enzymic mechanism of Candida tenuis xylose reductase (AKR 2B5): X-ray structure and catalytic reaction profile for the H113A mutant. Kratzer R, Kavanagh KL, Wilson DK, Nidetzky B. Biochemistry; 2004 May 04; 43(17):4944-54. PubMed ID: 15109252 [Abstract] [Full Text] [Related]
18. Mutational study of the role of tyrosine-49 in the Saccharomyces cerevisiae xylose reductase. Jeong EY, Sopher C, Kim IS, Lee H. Yeast; 2001 Aug 04; 18(11):1081-9. PubMed ID: 11481678 [Abstract] [Full Text] [Related]
19. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool. Akman SA, Dietrich M, Chlebowski R, Limberg P, Block JB. Cancer Res; 1985 Nov 04; 45(11 Pt 1):5257-62. PubMed ID: 2996758 [Abstract] [Full Text] [Related]
20. Mechanistic studies of morphine dehydrogenase and stabilization against covalent inactivation. Walker EH, French CE, Rathbone DA, Bruce NC. Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):687-92. PubMed ID: 10642529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]